Clinical Trials Browser

Phase 2 × Lymphoma, Mantle-Cell × temsirolimus × Clear all

NCT00109967 2014-04-17

CCI-779 and Rituximab in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

Phase 2 Completed

71 enrolled 10 charts

Lymphoma, Mantle-Cell

NCT00033267 2014-04-03

CCI-779 in Treating Patients With Mantle Cell Non-Hodgkin's Lymphoma

Phase 2 Completed

Lymphoma, Mantle-Cell